Torreele Els
Institute for Innovation and Public Purpose (IIPP), University College London, London, UK.
Development (Rome). 2020;63(2-4):191-199. doi: 10.1057/s41301-020-00261-1. Epub 2020 Nov 9.
Governments must become active shapers of medical innovation and drive the development of critical health technologies as global health commons. The 'race' for COVID-19 vaccines is exposing the deficiencies of a business-as-usual medical innovation ecosystem driven by corporate interests, not health outcomes. Instead of bolstering collective intelligence, it relies on competition between proprietary vaccines and allows the bar on safety and efficacy to be lowered, risking people's health and undermining their trust.
政府必须积极塑造医学创新，并推动关键健康技术作为全球公共卫生资源的发展。新冠疫苗的“竞赛”正暴露了一个由企业利益而非健康结果驱动的常规医学创新生态系统的缺陷。它没有增强集体智慧，而是依赖于专利疫苗之间的竞争，还降低了对安全性和有效性的标准，危及人们的健康并损害他们的信任。
